Focus Graphite Inc. (FMS.V) Competitors

Focus Graphite Inc. (FMS.V) (CVE:FMS) and InMed Pharmaceuticals Inc. (IN.TO) (TSE:IN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and InMed Pharmaceuticals Inc. (IN.TO)'s net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations for Focus Graphite Inc. (FMS.V) and InMed Pharmaceuticals Inc. (IN.TO), as reported by MarketBeat.

Valuation & Earnings

This table compares Focus Graphite Inc. (FMS.V) and InMed Pharmaceuticals Inc. (IN.TO)'s revenue, earnings per share and valuation.

Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than InMed Pharmaceuticals Inc. (IN.TO), indicating that it is currently the more affordable of the two stocks.

Summary

InMed Pharmaceuticals Inc. (IN.TO) beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.

TSO3 (TSE:TOS) and Focus Graphite Inc. (FMS.V) (CVE:FMS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares TSO3 and Focus Graphite Inc. (FMS.V)'s net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent recommendations and price targets for TSO3 and Focus Graphite Inc. (FMS.V), as provided by MarketBeat.

Valuation & Earnings

This table compares TSO3 and Focus Graphite Inc. (FMS.V)'s top-line revenue, earnings per share and valuation.

Focus Graphite Inc. (FMS.V) has lower revenue, but higher earnings than TSO3. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than TSO3, indicating that it is currently the more affordable of the two stocks.

Summary

TSO3 beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.

Assure (CVE:IOM) and Focus Graphite Inc. (FMS.V) (CVE:FMS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares Assure and Focus Graphite Inc. (FMS.V)'s net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Assure and Focus Graphite Inc. (FMS.V)'s top-line revenue, earnings per share and valuation.

Focus Graphite Inc. (FMS.V) has higher revenue and earnings than Assure. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than Assure, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Assure and Focus Graphite Inc. (FMS.V), as provided by MarketBeat.

Summary

Focus Graphite Inc. (FMS.V) beats Assure on 2 of the 3 factors compared between the two stocks.

Focus Graphite Inc. (FMS.V) (CVE:FMS) and Helius Medical Technologies (TSE:HSM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and Helius Medical Technologies' net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Focus Graphite Inc. (FMS.V) and Helius Medical Technologies' top-line revenue, earnings per share (EPS) and valuation.

Focus Graphite Inc. (FMS.V) has higher earnings, but lower revenue than Helius Medical Technologies. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Focus Graphite Inc. (FMS.V) and Helius Medical Technologies, as provided by MarketBeat.com.

Summary

Helius Medical Technologies beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.

Focus Graphite Inc. (FMS.V) (CVE:FMS) and Medexus Pharmaceuticals (CVE:MDP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and Medexus Pharmaceuticals' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Focus Graphite Inc. (FMS.V) and Medexus Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Focus Graphite Inc. (FMS.V) has higher earnings, but lower revenue than Medexus Pharmaceuticals. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than Medexus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Focus Graphite Inc. (FMS.V) and Medexus Pharmaceuticals, as provided by MarketBeat.

Medexus Pharmaceuticals has a consensus price target of C$5.00, indicating a potential downside of 28.77%. Given Medexus Pharmaceuticals' higher possible upside, analysts clearly believe Medexus Pharmaceuticals is more favorable than Focus Graphite Inc. (FMS.V).

Summary

Medexus Pharmaceuticals beats Focus Graphite Inc. (FMS.V) on 4 of the 5 factors compared between the two stocks.

Focus Graphite Inc. (FMS.V) (CVE:FMS) and ProMIS Neurosciences (TSE:PMN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and ProMIS Neurosciences' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Focus Graphite Inc. (FMS.V) and ProMIS Neurosciences' top-line revenue, earnings per share and valuation.

Focus Graphite Inc. (FMS.V) has higher earnings, but lower revenue than ProMIS Neurosciences. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than ProMIS Neurosciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations for Focus Graphite Inc. (FMS.V) and ProMIS Neurosciences, as provided by MarketBeat.

Summary

ProMIS Neurosciences beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.